Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …

Rheumatoid arthritis (RA) is considered a chronic disease that cannot be cured. Biologic
agents have enabled good therapeutic successes; however, the response to biologic …

Objectives Since the 2007 recommendations for the management of early arthritis have
been presented, considerable research has been published in the field of early arthritis …

Objective To investigate whether an intensive early rheumatoid arthritis (RA) treat-to-target
(T2T) strategy could be improved through the use of musculoskeletal ultrasound (MSUS) …

Since their first use for treating rheumatoid arthritis (RA) in the late 1940s, glucocorticoids
(GCs) have been representing a substantial part of the therapeutic arsenal for RA. However …

Abstract The 2014 French Society for Rheumatology (Société Française de Rheumatologie,
SFR) recommendations about the management of rheumatoid arthritis (RA) have been …

Hintergrund: Medikamentöse Therapiestrategien zur Behandlung der rheumatoiden Arthritis
sind entscheidend für den Langzeitverlauf. Sie dienen dem Ziel, durch frühe und …

Objectives To perform a systematic literature review (SLR) informing the 2016 update of the
recommendations for the management of rheumatoid arthritis (RA). Methods An SLR for the …

Abstract The IL-17A producing T-helper-17 (Th17) cell population plays a major role in
rheumatoid arthritis (RA) pathogenesis and has gained wide interest as treatment target. IL …

Objectives Combining disease-modifying antirheumatic drugs (DMARDs) with
glucocorticoids (GCs) is an effective treatment strategy for early rheumatoid arthritis (ERA) …